Allograft characteristics
| Characteristic . | Filgrastim (n = 23) . | Placebo (n = 21) . | PValue . |
|---|---|---|---|
| CD34+ infused (×106/kg) | |||
| Median | 10.36 | 8.12 | .44 |
| Range | 4.02-20.32 | 2.25-26.17 | |
| CFU-GM infused (×104/kg) | |||
| Median | 63.79 | 52.84 | .47 |
| Range | 20.33-165.77 | 13.21-178.40 | |
| MNC infused (×108/kg) | |||
| Median | 8.09 | 8.05 | .50 |
| Range | 2.95-15.77 | 5.38-14.94 |
| Characteristic . | Filgrastim (n = 23) . | Placebo (n = 21) . | PValue . |
|---|---|---|---|
| CD34+ infused (×106/kg) | |||
| Median | 10.36 | 8.12 | .44 |
| Range | 4.02-20.32 | 2.25-26.17 | |
| CFU-GM infused (×104/kg) | |||
| Median | 63.79 | 52.84 | .47 |
| Range | 20.33-165.77 | 13.21-178.40 | |
| MNC infused (×108/kg) | |||
| Median | 8.09 | 8.05 | .50 |
| Range | 2.95-15.77 | 5.38-14.94 |
CFU-GM indicates colony-forming units of granulocyte-macrophage; MNC, mononuclear cells.